Ira Zackon, MD, discusses bispecific antibody use in multiple myeloma among community practices, reflecting real-world treatment trends.
Ira Zackon, MD
Advertisement
Ira Zackon, MD, is a senior medical director at Ontada.
Articles by Ira Zackon, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Azacitidine/Venetoclax Combo Data Challenge Chemo in Fit Patients With AML
2
In Vivo CAR T Takes Center Stage, With Results Shared for 4 MRD-Negative Patients
3
Adolescents Saw Mental Health Gains After School Reopened Post Pandemic
4
Expanding Precision Care for Alzheimer Disease, Multiple Sclerosis
5
